🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Daniela R. Junqueira

Thermo Fisher Scientific (Canada)

ORCID: 0000-0002-3261-4811

Decision SciencesMedicineEconomics, Econometrics and Finance

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials”.

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

BMJ(2023)10.1136/bmj-2022-073725

N/A

0.749DataRank · unranked

146 citations

Liliane Zorzela, Steven A. Julious, Tianjing Li, Ba Pham, Rachel Phillips +11 more

Time to improve the reporting of harms in randomized controlled trials

Journal of Clinical Epidemiology(2021)10.1016/j.jclinepi.2021.04.020

N/A

0.587DataRank · unranked

49 citations

Rachel Phillips, Liliane Zorzela, Su Golder, Yoon K. Loke, David Moher +3 more

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomized trials

Journal of Clinical Epidemiology(2023)10.1016/j.jclinepi.2023.04.005

N/A

0.564DataRank · unranked

42 citations

Liliane Zorzela, Steven A. Julious, Tianjing Li, Ba Pham, Rachel Phillips +17 more

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

UNC Libraries(2024)10.17615/p6dm-ff76

N/A

0DataRank · unranked

0 citations

Liliane Zorzela, Su Golder, Y. K. Loke, Joel Gagnier, Steven A. Julious +12 more